Table 1. Body Weight Correlations.
Standard | Recovery | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Water | MP-Low | MP-High | Water | MP-Low | MP-High | ||||||||
R | p-value | R | p-value | R | p-value | R | p-value | R | p-value | R | p-value | ||
Femora | AP Diameter | 0.534 | 0.074 | 0.624 | <0.050 | 0.368 | 0.240 | −0.129 | 0.690 | 0.267 | 0.401 | 0.422 | 0.171 |
ML Diameter | 0.333 | 0.290 | 0.535 | 0.073 | 0.198 | 0.537 | 0.102 | 0.754 | 0.854 | <0.001 | 0.728 | <0.010 | |
Length | 0.834 | <0.001 | 0.491 | 0.105 | 0.596 | <0.050 | 0.056 | 0.864 | 0.886 | <0.001 | 0.068 | <0.050 | |
BMD | 0.087 | 0.789 | 0.578 | <0.050 | 0.490 | 0.106 | −0.170 | 0.597 | 0.680 | <0.050 | 0.779 | <0.010 | |
BMC | 0.678 | <0.050 | 0.807 | 0.001 | 0.648 | <0.050 | −0.172 | 0.592 | 0.892 | <0.001 | 0.816 | 0.001 | |
Area | 0.926 | <0.001 | 0.700 | 0.010 | 0.752 | <0.010 | −0.147 | 0.649 | 0.931 | <0.001 | 0.743 | <0.010 | |
Ultimate Force | 0.132 | 0.682 | 0.674 | <0.050 | 0.443 | 0.150 | 0.175 | 0.585 | 0.182 | 0.592 | 0.230 | 0.497 | |
Stiffness | 0.476 | 0.118 | 0.591 | <0.050 | 0.367 | 0.241 | −0.072 | 0.823 | 0.138 | 0.668 | 0.164 | 0.610 | |
Energy to Failure | 0.462 | 0.131 | 0.248 | 0.437 | 0.195 | 0.543 | 0.200 | 0.534 | 0.467 | 0.147 | 0.244 | 0.470 | |
Tibiae | BMD | 0.069 | 0.832 | 0.666 | <0.050 | 0.574 | 0.050 | −0.290 | 0.361 | 0.585 | <0.050 | 0.698 | 0.010 |
BMC | 0.641 | <0.050 | 0.809 | 0.001 | 0.620 | <0.050 | −0.252 | 0.429 | 0.805 | <0.010 | 0.783 | <0.010 | |
Area | 0.830 | <0.001 | 0.681 | <0.050 | 0.652 | <0.050 | −0.204 | 0.525 | 0.848 | <0.001 | 0.766 | <0.010 | |
Serum | CTX | 0.743 | 0.257 | 0.137 | 0.863 | −0.760 | 0.240 | 0.077 | 0.923 | −0.006 | 0.994 | 0.687 | 0.313 |
ALP | −0.266 | 0.457 | −0.270 | 0.396 | −0.554 | 0.062 | 0.036 | 0.911 | 0.325 | 0.302 | 0.041 | 0.899 | |
Testosterone | 0.389 | 0.267 | 0.212 | 0.532 | 0.067 | 0.864 | 0.386 | 0.27 | 0.312 | 0.324 | 0.659 | <0.050 |
This table presents the results of linear regression and correlation analyses performed between body weight at sacrifice and the caliper, DXA, biomechanics, and biomarker results from the three treatment groups (Water, MP-Low, and MP-High) analyzed immediately after 13 weeks of treatment (Standard) and following 5 weeks of untreated recovery (Recovery). Sample identities are given in the first column, followed by the outcomes, R-values, and p-values, for each treatment group and dosing protocol. Significant correlations are marked in bold.